Overview
Follow-up Study for Participants of Jointstem Phase 3 Clinical Trial
Status:
Enrolling by invitation
Enrolling by invitation
Trial end date:
2027-12-30
2027-12-30
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of this follow-up study is to investigate the efficacy and safety of autologous Adipose Tissue derived Mesenchymal stem cells (JOINTSTEM®) in patient with severe Knee Osteoarthritis.Phase:
Phase 3Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
R-Bio
Criteria
Inclusion Criteria:- Participants of Jointstem Phase 3 Clinical Trial
- Participates who signed informed consent document of this study
Exclusion Criteria:
- No applicable